Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold

The picornavirus foot-and-mouth disease virus (FMDV) is the causative agent of the economically important disease of livestock, foot-and-mouth disease (FMD). VP4 is a highly conserved capsid protein, which is important during virus entry. Previous published work has shown that antibodies targeting t...

Full description

Bibliographic Details
Main Authors: Jessica Swanson, Rennos Fragkoudis, Philippa C. Hawes, Joseph Newman, Alison Burman, Anusha Panjwani, Nicola J. Stonehouse, Tobias J. Tuthill
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/11/4/338
_version_ 1797538034878513152
author Jessica Swanson
Rennos Fragkoudis
Philippa C. Hawes
Joseph Newman
Alison Burman
Anusha Panjwani
Nicola J. Stonehouse
Tobias J. Tuthill
author_facet Jessica Swanson
Rennos Fragkoudis
Philippa C. Hawes
Joseph Newman
Alison Burman
Anusha Panjwani
Nicola J. Stonehouse
Tobias J. Tuthill
author_sort Jessica Swanson
collection DOAJ
description The picornavirus foot-and-mouth disease virus (FMDV) is the causative agent of the economically important disease of livestock, foot-and-mouth disease (FMD). VP4 is a highly conserved capsid protein, which is important during virus entry. Previous published work has shown that antibodies targeting the N-terminus of VP4 of the picornavirus human rhinovirus are broadly neutralising. In addition, previous studies showed that immunisation with the N-terminal 20 amino acids of enterovirus A71 VP4 displayed on the hepatitis B core (HBc) virus-like particles (VLP) can induce cross-genotype neutralisation. To investigate if a similar neutralising response against FMDV VP4 could be generated, HBc VLPs displaying the N-terminus of FMDV VP4 were designed. The N-terminal 15 amino acids of FMDV VP4 was inserted into the major immunodominant region. HBc VLPs were also decorated with peptides of the N-terminus of FMDV VP4 attached using a HBc-spike binding tag. Both types of VLPs were used to immunise mice and the resulting serum was investigated for VP4-specific antibodies. The VLP with VP4 inserted into the spike, induced VP4-specific antibodies, however the VLPs with peptides attached to the spikes did not. The VP4-specific antibodies could recognise native FMDV, but virus neutralisation was not demonstrated. This work shows that the HBc VLP presents a useful tool for the presentation of FMDV capsid epitopes.
first_indexed 2024-03-10T12:25:44Z
format Article
id doaj.art-0b56d8b0c2854872b35c69ca52c55120
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-10T12:25:44Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-0b56d8b0c2854872b35c69ca52c551202023-11-21T15:03:13ZengMDPI AGLife2075-17292021-04-0111433810.3390/life11040338Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a ScaffoldJessica Swanson0Rennos Fragkoudis1Philippa C. Hawes2Joseph Newman3Alison Burman4Anusha Panjwani5Nicola J. Stonehouse6Tobias J. Tuthill7The Pirbright Institute, Pirbright GU24 0NF, UKThe Pirbright Institute, Pirbright GU24 0NF, UKThe Pirbright Institute, Pirbright GU24 0NF, UKThe Pirbright Institute, Pirbright GU24 0NF, UKThe Pirbright Institute, Pirbright GU24 0NF, UKThe Pirbright Institute, Pirbright GU24 0NF, UKFaculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UKThe Pirbright Institute, Pirbright GU24 0NF, UKThe picornavirus foot-and-mouth disease virus (FMDV) is the causative agent of the economically important disease of livestock, foot-and-mouth disease (FMD). VP4 is a highly conserved capsid protein, which is important during virus entry. Previous published work has shown that antibodies targeting the N-terminus of VP4 of the picornavirus human rhinovirus are broadly neutralising. In addition, previous studies showed that immunisation with the N-terminal 20 amino acids of enterovirus A71 VP4 displayed on the hepatitis B core (HBc) virus-like particles (VLP) can induce cross-genotype neutralisation. To investigate if a similar neutralising response against FMDV VP4 could be generated, HBc VLPs displaying the N-terminus of FMDV VP4 were designed. The N-terminal 15 amino acids of FMDV VP4 was inserted into the major immunodominant region. HBc VLPs were also decorated with peptides of the N-terminus of FMDV VP4 attached using a HBc-spike binding tag. Both types of VLPs were used to immunise mice and the resulting serum was investigated for VP4-specific antibodies. The VLP with VP4 inserted into the spike, induced VP4-specific antibodies, however the VLPs with peptides attached to the spikes did not. The VP4-specific antibodies could recognise native FMDV, but virus neutralisation was not demonstrated. This work shows that the HBc VLP presents a useful tool for the presentation of FMDV capsid epitopes.https://www.mdpi.com/2075-1729/11/4/338picornavirusFMDVVLPcapsidantibodies
spellingShingle Jessica Swanson
Rennos Fragkoudis
Philippa C. Hawes
Joseph Newman
Alison Burman
Anusha Panjwani
Nicola J. Stonehouse
Tobias J. Tuthill
Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
Life
picornavirus
FMDV
VLP
capsid
antibodies
title Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
title_full Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
title_fullStr Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
title_full_unstemmed Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
title_short Generation of Antibodies against Foot-and-Mouth-Disease Virus Capsid Protein VP4 Using Hepatitis B Core VLPs as a Scaffold
title_sort generation of antibodies against foot and mouth disease virus capsid protein vp4 using hepatitis b core vlps as a scaffold
topic picornavirus
FMDV
VLP
capsid
antibodies
url https://www.mdpi.com/2075-1729/11/4/338
work_keys_str_mv AT jessicaswanson generationofantibodiesagainstfootandmouthdiseaseviruscapsidproteinvp4usinghepatitisbcorevlpsasascaffold
AT rennosfragkoudis generationofantibodiesagainstfootandmouthdiseaseviruscapsidproteinvp4usinghepatitisbcorevlpsasascaffold
AT philippachawes generationofantibodiesagainstfootandmouthdiseaseviruscapsidproteinvp4usinghepatitisbcorevlpsasascaffold
AT josephnewman generationofantibodiesagainstfootandmouthdiseaseviruscapsidproteinvp4usinghepatitisbcorevlpsasascaffold
AT alisonburman generationofantibodiesagainstfootandmouthdiseaseviruscapsidproteinvp4usinghepatitisbcorevlpsasascaffold
AT anushapanjwani generationofantibodiesagainstfootandmouthdiseaseviruscapsidproteinvp4usinghepatitisbcorevlpsasascaffold
AT nicolajstonehouse generationofantibodiesagainstfootandmouthdiseaseviruscapsidproteinvp4usinghepatitisbcorevlpsasascaffold
AT tobiasjtuthill generationofantibodiesagainstfootandmouthdiseaseviruscapsidproteinvp4usinghepatitisbcorevlpsasascaffold